SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001624422-21-000033
Filing Date
2021-07-30
Accepted
2021-07-30 10:09:28
Documents
5
Period of Report
2021-07-29

Document Format Files

Seq Description Document Type Size
1 6-K eryp_6-kx07292021.htm 6-K 17825
2 EX-99.1 ex-991eryp_6xkx07292021.htm EX-99.1 25871
3 GRAPHIC image1a.jpg GRAPHIC 9240
4 GRAPHIC image2a.jpg GRAPHIC 9117
5 GRAPHIC imagea.jpg GRAPHIC 2689
  Complete submission text file 0001624422-21-000033.txt   74234
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38281 | Film No.: 211130551
SIC: 2836 Biological Products, (No Diagnostic Substances)